|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Lim L, Michael M, Mann GB and Leong T:
Adjuvant therapy in gastric cancer. J Clin Oncol. 23:6220–6232.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Zhang Y, Yang L, et al: Arsenic
trioxide induces the apoptosis of human breast cancer MCF-7 cells
through activation of caspase-3 and inhibition of HERG channels.
Exp Ther Med. 2:481–486. 2011.PubMed/NCBI
|
|
4
|
Zhou J: Arsenic trioxide: an ancient drug
revived. Chin Med J. 125:3556–3560. 2012.PubMed/NCBI
|
|
5
|
Shen ZY, Shen J, Cai WJ, Hong C and Zheng
MH: The alteration of mitochondria is an early event of arsenic
trioxide induced apoptosis in esophageal carcinoma cells. Int J Mol
Med. 5:155–158. 2000.PubMed/NCBI
|
|
6
|
Shen ZY, Zhang Y, Chen JY, et al:
Intratumoral injection of arsenic to enhance antitumor efficacy in
human esophageal carcinoma cell xenografts. Oncol Rep. 11:155–159.
2004.PubMed/NCBI
|
|
7
|
Chow SK, Chan JY and Fung KP: Inhibition
of cell proliferation and the action mechanisms of arsenic trioxide
(As2O3) on human breast cancer cells. J Cell
Biochem. 93:173–187. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye J, Li A, Liu Q, Wang X and Zhou J:
Inhibition of mitogen-activated protein kinase enhances apoptosis
induced by arsenic trioxide in human breast cancer MCF-7 cells.
Clin Exp Pharmacol Physiol. 32:1042–1048. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jutooru I, Chadalapaka G, Sreevalsan S, et
al: Arsenic trioxide downregulates specificity protein (Sp)
transcription factors and inhibits bladder cancer cell and tumor
growth. Exp Cell Res. 316:2174–2188. 2010. View Article : Google Scholar
|
|
10
|
Chien CW, Yao JH, Chang SY, Lee PC and Lee
TC: Enhanced suppression of tumor growth by concomitant treatment
of human lung cancer cells with suberoylanilide hydroxamic acid and
arsenic trioxide. Toxicol Appl Pharmacol. 257:59–66. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Gong J, Jiang X and Shao H: Arsenic
trioxide treatment of rabbit liver VX-2 carcinoma via hepatic
arterial cannulation-induced apoptosis and decreased levels of
survivin in the tumor tissue. Croat Med J. 54:12–16. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matulis SM, Morales AA, Yehiayan L, Lee
KP, Cai Y and Boise LH: Alterations in glutathione levels and
apoptotic regulators are associated with acquisition of arsenic
trioxide resistance in multiple myeloma. PloS One. 7:e526622012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ora I, Bondesson L, Jonsson C, et al:
Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes
apoptotic cell death in vitro. Biochem Biophys Res Commun.
277:179–185. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakagawa Y, Akao Y, Morikawa H, et al:
Arsenic trioxide-induced apoptosis through oxidative stress in
cells of colon cancer cell lines. Life Sci. 70:2253–2269. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bornstein J, Sagi S, Haj A, Harroch J and
Fares F: Arsenic trioxide inhibits the growth of human ovarian
carcinoma cell line. Gynecol Oncol. 99:726–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Zhang W, Zhang X, Qi Y, Huang D and
Zhang Y: Arsenic trioxide inhibits invasion/migration in SGC-7901
cells by activating the reactive oxygen species-dependent
cyclooxygenase-2/matrix metalloproteinase-2 pathway. Exp Biol Med.
236:592–597. 2011. View Article : Google Scholar
|
|
17
|
Bowling BD, Doudican N, Manga P and Orlow
SJ: Inhibition of mitochondrial protein translation sensitizes
melanoma cells to arsenic trioxide cytotoxicity via a reactive
oxygen species dependent mechanism. Cancer Chemother Pharmacol.
63:37–43. 2008. View Article : Google Scholar
|
|
18
|
Florea AM and Büsselberg D: Anti-cancer
drugs interfere with intracellular calcium signaling.
Neurotoxicology. 30:803–810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao F, Yi J, Shi GY, Li H, Shi XG and Tang
XM: The sensitivity of digestive tract tumor cells to
As2O3 is associated with the inherent
cellular level of reactive oxygen species. World J Gastroenterol.
8:36–39. 2002.PubMed/NCBI
|
|
20
|
Izdebska M, Grzanka A, Szczepanski MA and
Litwiniec A: Selected mechanisms of the therapeutic effect of
arsenic trioxide in cancer treatment. Postepy Hig Med Dosw.
62:463–467. 2008.(In Polish).
|
|
21
|
Calvino E, Estan MC, Simon GP, et al:
Increased apoptotic efficacy of lonidamine plus arsenic trioxide
combination in human leukemia cells. Reactive oxygen species
generation and defensive protein kinase (MEK/ERK, Akt/mTOR)
modulation. Biochem Pharmacol. 82:1619–1629. 2011. View Article : Google Scholar
|
|
22
|
Carracedo A and Pandolfi PP: The PTEN-PI3K
pathway: of feedbacks and cross-talks. Oncogene. 27:5527–5541.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Markman B, Dienstmann R and Tabernero J:
Targeting the PI3K/Akt/mTOR pathway - beyond rapalogs. Oncotarget.
1:530–543. 2010.PubMed/NCBI
|
|
24
|
Hay N: The Akt-mTOR tango and its
relevance to cancer. Cancer Cell. 8:179–183. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meijer AJ and Codogno P: Regulation and
role of autophagy in mammalian cells. Int J Biochem Cell Biol.
36:2445–2462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Redondo-Munoz J, Escobar-Diaz E, Hernandez
Del Cerro M, et al: Induction of B-chronic lymphocytic leukemia
cell apoptosis by arsenic trioxide involves suppression of the
phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2
terminal kinase activation and PTEN upregulation. Clin Cancer Res.
16:4382–4391. 2010. View Article : Google Scholar
|
|
28
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Komarov AP, Rokhlin OW, Yu CA and Gudkov
AV: Functional genetic screening reveals the role of mitochondrial
cytochrome b as a mediator of FAS-induced apoptosis. Proc Natl Acad
Sci USA. 105:14453–14458. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suen DF, Norris KL and Youle RJ:
Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han B, Zhou G, Zhang Q, et al: Effect of
arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO
induced apoptosis of PG cells and decreased expression of Bcl-2,
Pgp. J Exp Ther Oncol. 4:335–342. 2004.PubMed/NCBI
|
|
33
|
Guertin DA and Sabatini DM: Defining the
role of mTOR in cancer. Cancer Cell. 12:9–22. 2007. View Article : Google Scholar
|
|
34
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Brunet A, Bonni A, Zigmond MJ, et al: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Diehl JA, Cheng M, Roussel MF and Sherr
CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis
and subcellular localization. Genes Dev. 12:3499–3511. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Engelman JA, Luo J and Cantley LC: The
evolution of phosphatidylinositol 3-kinases as regulators of growth
and metabolism. Nat Rev Genet. 7:606–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen YC, Lin-Shiau SY and Lin JK:
Involvement of reactive oxygen species and caspase 3 activation in
arsenite-induced apoptosis. J Cell Physiol. 177:324–333. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Woo SH, Park IC, Park MJ, et al: Arsenic
trioxide induces apoptosis through a reactive oxygen
species-dependent pathway and loss of mitochondrial membrane
potential in HeLa cells. Int J Oncol. 21:57–63. 2002.
|
|
40
|
Pelicano H, Feng L, Zhou Y, et al:
Inhibition of mitochondrial respiration: a novel strategy to
enhance drug-induced apoptosis in human leukemia cells by a
reactive oxygen species-mediated mechanism. J Biol Chem.
278:37832–37839. 2003. View Article : Google Scholar
|
|
41
|
Diepart C, Karroum O, Magat J, et al:
Arsenic trioxide treatment decreases the oxygen consumption rate of
tumor cells and radiosensitizes solid tumors. Cancer Res.
72:482–490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ling LU, Tan KB, Lin H and Chiu GN: The
role of reactive oxygen species and autophagy in safingol-induced
cell death. Cell Death Dis. 2:e1292011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang G, Liu J, Zhang Y, et al:
Cbl-b-dependent degradation of FLIP(L) is involved in ATO-induced
autophagy in leukemic K562 and gastric cancer cells. FEBS Lett.
586:3104–3110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cheng Y, Qiu F, Ye YC, et al: Autophagy
inhibits reactive oxygen species-mediated apoptosis via activating
p38-nuclear factor-kappa B survival pathways in oridonin-treated
murine fibrosarcoma L929 cells. FEBS J. 276:1291–1306. 2009.
View Article : Google Scholar
|
|
45
|
Dai J, Weinberg RS, Waxman S and Jing Y:
Malignant cells can be sensitized to undergo growth inhibition and
apoptosis by arsenic trioxide through modulation of the glutathione
redox system. Blood. 93:268–277. 1999.PubMed/NCBI
|
